Back to User profile » Dr Richard Kim
Papers published by Dr Richard Kim:
Critique on “Real-World Effectiveness of First-Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights” [Response to Letter]
Biachi de Castria T, Kim RD
Pragmatic and Observational Research 2024, 15:91-92
Published Date: 10 July 2024
Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights
Biachi de Castria T, Kim RD
Pragmatic and Observational Research 2024, 15:79-87
Published Date: 10 June 2024
Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
Yu J, Park R, Kim R
Journal of Hepatocellular Carcinoma 2023, 10:1105-1127
Published Date: 18 July 2023
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib
Yu J, Mahipal A, Kim R
OncoTargets and Therapy 2021, 14:5145-5160
Published Date: 23 October 2021
The Impact of Ramucirumab Treatment on Survival and Quality of Life in Patients with Gastric Cancer
Mehta R, Kommalapati A, Kim RD
Cancer Management and Research 2020, 12:51-57
Published Date: 7 January 2020
Expression of Her-2/neu in extrahepatic cholangiocarcinoma
Shamekh R, Rosa M, Sayegh Z, Ghayouri M, Kim R, Malafa MP, Coppola D
Pathology and Laboratory Medicine International 2017, 9:9-14
Published Date: 15 February 2017